Clinical Briefs in Primary Care – January 1, 2016
January 1, 2016
View Issues
-
Spironolactone Best Add-on for Resistant Hypertension
Spironolactone provided statistically significant greater reductions in blood pressure than two other active agents.
-
Good Cardiovascular News from the SGLT2 Inhibitor Class?
The widely celebrated results of a recent landmark trial give at least one physician reasons to pause.
-
Vitamin D: Conclusions From an NIH Conference
Observational studies indicate that low vitamin D status is associated with risk for cardiovascular disease, cancer, diabetes, and other important disorders, but whether this relationship is causal is not yet known, and whether correction of such a causal relationship (if established) will improve outcomes remains to be determined.
-
Prostate Cancer Screening: Have Clinicians Been Listening?
Published modeling methods suggest an increase in prostate cancer mortality by omission of universal screening; to date, that has not been the case, but may require a longer window of observation before reaching definitive conclusions.
-
Potential Benefits of Down Titration Through Inhaled Steroid Discontinuation
The likelihood of serious pneumonia was reduced by 37% in patients who discontinued inhaled corticosteroids vs those who did not.
-
Expanding Safe Prescribing for Metformin
In an era of progressively more expensive interventions for type 2 diabetes, clinicians may wish to re-evaluate the boundaries of safe prescribing for metformin.